Conversion coefficients were calculated for fluence-to-absorbed dose, fluence-to-equivalent dose, fluence-to-effective dose and fluence-to-gray equivalent, for isotropic exposure of an adult male and an adult female to helions (  3 He   21 
INTRODUCTION
Fluence-to-dose conversion coefficients are used to estimate doses produced by an external radiation field. Previously published coefficients for light ions (deuterons, tritons, helions and alpha particles) exist for energies up to 3 GeV per nucleon (1, 2) . Improvements in computer technology and in Monte Carlo transport codes have facilitated Monte Carlo calculation of conversion coefficients for these ions over a much wider energy range. While not present in significant numbers in primary galactic cosmic radiation (3) , the helion, a fully ionised helium-3 ( 3 He 2þ ) atom, is important because of its health effects and its abundance in secondary galactic cosmic radiation in space and in the atmosphere at high altitudes (4) . To estimate risk of stochastic effects, the International Commission on Radiological Protection (ICRP) recommends effective dose as a radiation protection quantity for general application, including aviation at high altitudes and space exploration (5) . ICRP defines effective dose as a sex-averaged quantity calculated for a 'Reference Person' (ref. (5) , pp. 274-275). ICRP recommends radiation weighting factors (w R ) for calculation of equivalent dose to specific tissues and effective dose from exposure to radiation externally incident on the body. No w R is specified by ICRP for helions. However, for alpha particles and heavy ions externally incident on the body, ICRP recommends a w R of 20 (ref. (5) , p. 64), while recognising that data for biological effects is limited and its current recommendation is a conservative estimate and may be inadequate for space applications (ref. (5) , p. 68). The value of w R represents radiation quality averaged over the different tissues and organs of the body. It takes into account that the actual radiation field varies owing to attenuation and degradation of the primary radiation and production of secondary radiations of different radiation quality (ref. (5) , Para B 79, p. 276). Because helions and alpha particles have the same charge and similar masses, when traveling at the same speed they will have essentially identical LET and track structure (6) . Therefore, the w R for alpha particles was used for helions in the present study, as was done by Sato et al. (2) . For occupationally exposed persons other than astronauts, the National Council on Radiation Protection and Measurements (NCRP), like the ICRP, recommends calculating effective dose using radiation weighting factors and tissue-equivalent doses (7) . However, to calculate effective dose for astronauts NCRP uses dose equivalent, which is the common practice in the space-radiation protection community (8, 9) . NCRP considers dose equivalent and equivalent dose interchangeable for radiation protection purposes in low-Earth orbit (8) . ICRP recommends equivalent dose limits for deterministic effects in occupationally exposed persons (5) . For occupationally exposed persons other than astronauts, NCRP also recommends equivalent dose limits for deterministic effects (7) recommends gray equivalent (absorbed doseÂRBE) to estimate incidence of deterministic effects and set limits (4, 8, 9) . NCRP recommends an RBE of 2.5 for helium and other heavy ions and notes that recommended RBE values are averages and not accurate for all deterministic effects (e.g. cataracts) (8, 9) . Presented here are fluence-to-absorbed dose (Gy . cm 2 ), fluence-to-equivalent dose (Sv . cm 2 ), fluenceto-effective dose (Sv . cm 2 ) and fluence-to-gray equivalent (Gy-Eq . cm 2 ) conversion coefficients for isotropic exposure to helions in the energy range of 10 MeV to 1 TeV (0.02-1000 GeV).
METHODS

Radiation transport
The Monte Carlo radiation transport code MCNPX 2.7.C (10) , with additional cross-sectional libraries distributed with MCNPX 2.6.0 (11) , was used to simulate isotropic exposure of an adult male and an adult female to helions in the energy range of 0.01 -1000 GeV. Particles selected for secondary transport were light ions (deuterons, tritons, helions and alpha particles), protons, neutrons, pions, kaons, photons, electrons, muons, tauons and neutrinos. Physics models in MCNPX were selected such that for interactions at energies above those in the tables, the most modern models available were used: LAQGSM 3.02 for light ion transport above 0.940 GeV/ nucleon and for protons and neutrons; FLUKA89 for anti-nucleons and kaons .0.800 GeV; ISABEL for anti-nucleons and kaons ,0.800 GeV; CEM 3.02 for other transport (10, 11) .
Anthropomorphic phantoms
For consistency with previously published coefficients for alpha particles and iron ions (12, 13) , modified BodyBuilder TM ver. 1.3 (14) male and female phantoms, which are based on models described by Cristy and Eckerman (15) were used. For a complete list of changes made to the phantoms, see ref. (12) . The important assumptions and reasons for accepting them were the following.
(1) The oral mucosa dose was also used as the dose to the salivary glands. (2) The dose to muscle was used as the dose to lymph nodes, since lymph nodes and muscle are distributed similarly in the body. (3) The dose to female breasts was used as the dose to male breasts, since the male phantom has no breasts. This procedure was used in ICRP Publication 74 (16) and is discussed in ref.
(5) ( p. 274). (4) The dose to a whole bone was used as the dose to the bone surface and any red bone marrow within, since the phantoms do not differentiate between bone surface and interior. The approximations for bone and red bone marrow were tested using a simple cylindrically symmetric model (cortical bone surrounding adipose tissue beneath 5 cm of muscle) and found to be reasonable (less than a 10 % difference in results) at the energies used in the study. In all cases, material compositions were from ICRU Report 49 (17) . (5) A weighted average of doses to bones containing red bone marrow was used as the dose to red bone marrow. Weighting factors used were estimated fractions of red bone marrow in the bones of an adult (18) . (In the source for the red bone marrow distribution, the data were rounded to the nearest per cent and the percentages summed to 99. Thus, the fractions used were: sternum 3/99, vertebrae 25/99, upper limbs 4/99, skull 7/99, lower limbs 11/99, ribs 19/99 and pelvis 30/99.) (6) The dose to the head skin was used as the dose to the eye lens because the phantoms lacked eyes and they are both thin tissues at or near the surface of the head.
Calculation of conversion coefficients
With minor differences, the methods used to calculate coefficients were as described in refs (12) and (13) . The general steps and assumptions were the following.
(1) For each primary particle energy and tissue, a fluence-to-absorbed dose conversion coefficient and coefficient of variation (CV, standard deviation divided by mean) were calculated. Calculations were stopped if either 5.00Eþ07 simulations were run or the largest CV for all tissues became less than 0.01. (2) For each primary particle energy in Table 3, as was done by Sato et al. (2) , for each tissue the fluence-to-equivalent dose conversion coefficient was calculated by multiplying the fluenceto-absorbed dose conversion coefficient by a radiation weighting factor (w R ) of 20, as recommended by the ICRP for alpha particles and heavy ions incident on the human body (5) . While the ICRP does not make a specific w R recommendation for helions, this value of w R was considered reasonable because helions have essentially the same LET and track structure as alpha particles when traveling at the same speed (though a shorter range) (6) . (3) For each primary particle energy in Table 4 , fluence-to-effective dose conversion coefficients were calculated from fluence-to-equivalent dose conversion coefficients. (4) For each primary particle energy and tissue in Table 5 , the sex-averaged fluence-to-gray equivalent conversion coefficients were calculated from the fluence-to-absorbed dose conversion coefficients by multiplying the fluence-toabsorbed dose conversion coefficient by an RBE of 2.5 (8) .
Calculation of coefficients of variation
As noted in the preceding section, CVs for the fluence-to-absorbed dose conversion coefficients were calculated for each tissue in each sex. They indicate the repeatability of the calculations. CVs for the fluence-to-equivalent dose conversion coefficients are numerically the same as those calculated for the fluence-to-absorbed dose conversion coefficients. Except for breasts, when calculating a CV for a sex-averaged fluence-to-equivalent dose conversion coefficient, the dose to each sex was assumed to be independent. The formula used to sex average the CVs is shown in the footnote to Table 3 . For breasts, the female CVs were used. At each energy, a CV for each fluence-to-effective dose conversion coefficient was calculated using the CVs calculated for the sex-averaged fluence-toequivalent dose conversion coefficients for the tissues, assuming independence of doses to each tissue. The formula used to calculate CV for each fluence-to-effective dose conversion coefficient is in the first footnote to Table 4. CV for each whole-body fluence-to-gray equivalent conversion coefficient was calculated in the same manner as the corresponding fluence-to-effective dose conversion coefficient, except that tissue weighting factors were replaced with the fractions of total body mass.
RESULTS
Fluence-to-absorbed dose conversion coefficients for isotropic exposure to helions for tissues in female and male phantoms are shown in Tables 1 and 2 , respectively. The data in Tables 3 -5 were calculated from the data in Tables 1 and 2. Table 3 shows sex-averaged fluence-to-equivalent dose conversion coefficients for skin and eye lens, calculated using a w R of 20. Table 4 shows adult female, adult male and sex- 
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Ion energy (GeV) (11) . Results with a CV .0.1 were considered unreliable and not reported (11) .
averaged fluence-to-effective dose conversion coefficients for isotropic exposure to helions, calculated using ICRP 2007 recommended tissue weighting factors and a w R of 20. Table 5 shows sexaveraged fluence-to-gray equivalent conversion coefficients for bone marrow, eye lens, skin and the whole body, calculated using an RBE of 2.5. Figure 1 shows: (a) (circles) sex-averaged fluenceto-effective dose conversion coefficients from Table 3 ; (b) (triangles) coefficients reported by Sato et al. (2) , who used a modified MIRD5 phantom (15) , ICRP 1990 recommended tissues and tissue weighting factors (19) , the PHITS transport code (20) for heavy ions and hadrons (except low-energy neutrons), the MCNP4C transport code (21) for lowenergy neutrons and the EGS4 transport code (22) for photons, electrons and positrons; and (c) (crosses) coefficients obtained by modifying the methods of this report to incorporate ICRP 1990 recommended tissues and tissue weighting factors (19) . The phantom used by Sato et al. and those used in the methods of this report are modified versions of the phantoms of Cristy and Eckerman (2, 14, 15) . There is very little difference in the three sets of coefficients. At 15 of 19 energies, ICRP 2007 recommendations for calculation of effective dose result in coefficients within 2 % of those calculated using ICRP 1990 recommendations. The greatest difference, 62 %, occurs at 100 MeV.
CONCLUSIONS
Using Monte Carlo methods, the energy range of coefficients for converting isotropic exposure to helions to effective dose was extended to 1 TeV (1000 GeV). Where energies are similar, the coefficients of this report agree well with those published by Sato et al. (2) . The use of ICRP 2007 recommended tissues and tissue weighting factors instead of ICRP 1990 recommended tissues and tissue weighting factors makes very little difference at energies where comparisons were made. The pattern of changes in coefficients is consistent with the pattern for protons reported by Sato et al. (23) and suggests that, with regards to externally incident radiation, the most important change in the tissue weighting factors is the increase in the weighting factor for breast.
The presented fluence-to-absorbed dose, fluenceto-equivalent dose, fluence-to-effective dose and fluence-to-gray equivalent conversion coefficients for isotropic exposure to helions in the energy 
where C S is the fluence-to-equivalent dose conversion coefficient for sex S (S ¼ female or male) and CV S is the CV of C S (from MCNPX). range of 10 MeV to 1 TeV (0.01 -1000 GeV) will, as part of a larger set, facilitate dose estimates during air and space travel. For space applications in particular, the coefficients will be helpful in comparisons of ICRP's effective dose (5) , typically used for doses to aircraft occupants, with NCRP's effective dose equivalent (8) , which is typically used for spacecraft occupants. They will also be useful for comparisons of coefficients and doses calculated with the popular, but older, MIRD style phantoms with those calculated using newer voxel phantoms such as those recently adopted by the ICRP (24) . As noted in the Introduction, the ICRP may decide that a single radiation weighting factor is too conservative for all types and energies of alpha particles and heavy ions in space and high-altitude aviation (5) . If ICRP changes the recommended radiation weighting factor for alpha particles or the tissue weighting factors, revised conversion coefficients can be calculated from the presented fluence-to-absorbed dose conversion coefficients. The fluence-to-absorbed dose coefficients also will enable gray equivalent values to be recalculated if the NCRP alters its recommended RBE for helions. Figure 1 . Fluence-to-effective dose conversion coefficients for 3 He 2þ ions calculated by: (a) the method in this report, which used ICRP 2007 recommended tissues and tissue weighting factors (5) ; (b) Sato et al. (2) , who used ICRP 1990 recommendations (17) ; and (c) the method in this report modified to use ICRP 1990 recommended tissues and tissue weighting factors. The radiation weighting factor of 20 is the same in both the 1990 and the 2007 ICRP recommendations and is applied in all three methods. Plotted points are in the centre of the symbols. Size of the symbol for each point is unrelated to and much larger than the CV of the plotted data. 
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